NCB-0970

CAT: 0804-HY-100830A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-100830A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
NCB-0970 is the negative control of NCB-0846 (HY-100830) . NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation[1][2].
CAS Number
[2749881-54-5]
UNSPSC
12352005
Target
MAP4K; TGF-beta/Smad; Wnt
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ncb-0970.html
Purity
98.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@H](CC1)CC[C@@H]1OC2=CC=CC3=C2N=C(NC4=CC=C(N=CN5)C5=C4)N=C3
Molecular Formula
C21H21N5O2
Molecular Weight
375.42
References & Citations
[1]Masuda M, et al. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun. 2016 Aug 26;7:12586. |[2]Sugano T, et al., Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846. Br J Cancer. 2021 Jan;124 (1) :228-236.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAP4K7/TNIK

Related Products

CatalogName
HY-100830-01NCB-0846
HY-100830RNCB-0846 (Standard)
HY-149158-01CCC-0975
HY-118208-01ML-097
HY-13537BPR1J-097
HY-13537A-01BPR1J-097 Hydrochloride

Alternative Products

CatalogName
MBS131675-01NCB-0846
A20535-1NCB-0846 1mg
A20535-5NCB-0846 5mg
A20535-25NCB-0846 25mg
A20535-10NCB-0846 10mg
A20535-50NCB-0846 50mg
A20535-100NCB-0846 100mg
A20535-10mM-DNCB-0846 10mM * 1mL in DMSO
MBS1236080Recombinant Adenylosuccinate synthetase (LbrM13_V2.0970, LbrM_13_0970), partial

Popular Products